Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
0.9464
+0.0047 (0.50%)
At close: Oct 2, 2026, 4:00 PM EDT
0.9400
-0.0064 (-0.68%)
After-hours: Oct 2, 2026, 6:41 PM EDT
Creative Medical Technology Holdings Employees
Creative Medical Technology Holdings had 4 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$750
Profits / Employee
-$1,510,165
Market Cap
6.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - |
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| Lunai Bioworks | 29 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Alzamend Neuro | 6 |
| Enveric Biosciences | 6 |
CELZ News
- 16 days ago - Creative Medical files new U.S. provisional patent application for Ultrasome - TheFly
- 16 days ago - Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing - GlobeNewsWire
- 6 weeks ago - Roth believes Creative Medical’s ADAPT trial in CLBO ‘likely to succeed’ - TheFly
- 6 weeks ago - Creative Medical completes enrollment in ADAPT clinical trial - TheFly
- 6 weeks ago - Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning - GlobeNewsWire
- 1 month ago - Creative Medical receives notice of allowance for new U.S. patent - TheFly
- 1 month ago - Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms - GlobeNewsWire
- 2 months ago - Creative Medical files to sell 5.58M shares of common stock for holders - TheFly